Life Tech Inks CDx Deal with GlaxoSmithKline; Gets China OK for 3500 Dx Genetic Analyzers | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies has forged a partnership with GlaxoSmithKline Biologicals to develop a companion diagnostic test for GSK's candidate cancer immunotherapy, and gained regulatory approval in China for its Applied Biosystems 3500 Dx Genetic Analyzer, it announced separately after the close of the market on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.